DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR TANEZUMAB
» See Plans and Pricing
Clinical Trials for Tanezumab
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT00545129 | A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone | Completed | Pfizer | Phase 2 | The purpose of this study is to investigate the safety and efficacy of tanezumab in combination with opioids in treating pain due to cancer that has spread to bone. |
NCT00669409 | A Phase 1/2A, Single Dose Study Of PF-04383119 In Japanese Patients With Moderate To Severe Pain From Osteoarthritis Of The Knee | Completed | Pfizer | Phase 1/Phase 2 | To evaluate the safety and tolerability of single IV doses of PF-04383119 in Japanese patients with moderate to severe pain from OA of the knee (Part I). To evaluate the preliminary analgesic efficacy of PF-04383119 in Japanese patients with moderate to severe pain from OA of the knee in comparison with placebo (Part I and Part II). |
NCT00784693 | A Clinical Study To Investigate The Effectiveness And Safety Of Tanezumab In Treating Pain Associated With Endometriosis | Terminated | Pfizer | Phase 2 | The purpose of this study is to determine whether tanezumab is effective and safe in the treatment of pain associated with endometriosis. |
NCT00809354 | Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip | Terminated | Pfizer | Phase 3 | The purpose of this study is to investigate the long-term analgesic efficacy and safety of tanezumab for patients with osteoarthritis (OA) of the knee or hip currently experiencing partial benefit from, and are tolerating, non-steroidal anti-inflammatory drug (NSAID) therapy. |
NCT00826514 | An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis | Completed | Pfizer | Phase 2 | The purpose of this study is to determine whether tanezumab is effective in the treatment of pain associated with chronic prostatitis. |
NCT00830063 | Tanezumab In Osteoarthritis Of The Knee (2) | Completed | Pfizer | Phase 3 | The purpose of this study is to test the efficacy and safety of 2 doses of tanezumab compared with naproxen and placebo in patients with osteoarthritis. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Tanezumab
Condition Name
Clinical Trial Locations for Tanezumab
Trials by Country
Clinical Trial Progress for Tanezumab
Clinical Trial Phase
Clinical Trial Sponsors for Tanezumab
Sponsor Name